Illness	Number of cases
Malignant neoplasm of breast (C50.4)	162
Malignant neoplasm of breast (C50.8)	157
Hypertrophy of breast (N62)	62
Carcinoma in situ of breast (D05.1)	60
Malignant neoplasm of breast (C50.2)	48
Malignant neoplasm of breast (C50.9)	46
Malignant neoplasm of breast (C50.5)	31
Complications of other internal prosthetic devices implants and grafts (T85.4)	23
Malignant neoplasm of breast (C50.1)	22
Unspecified lump in breast (N63)	22

Top 10 treatments

Treatment	Number
Function-orientated physical exercises and uses (8-561.1)	398
X-rays of the breast (3-100.1)	350
Taking a tissue sample (biopsy) of other organs or tissues with a needle (1-493.32)	323
Surgical removal of individual lymph nodes or lymphatic vessels (5-401.11)	322
Gamma probe measurement when removing a particular lymph node in cancerous diseases, e.g. with breast cancer (3-760)	316
Imaging procedure to show the lymphatic system by means of radioactivity (scintigraphy) (3-709.00)	313
Gamma probe measurement to localise a tumour (3-762)	307
X-rays of the breast (3-100.0)	213
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.a2)	205
Surgical removal of individual lymph nodes or lymphatic vessels (5-401.10)	172

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2425

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
111	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
9	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
9	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Doctoral supervision
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year)
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies